Global Blood Micro-Sampling Medical Devices Market is
New York, Jan. 29, 2025 (GLOBE NEWSWIRE) --
The blood microsampling medical device market is experiencing growth as this method is crucial to providing secure, fast, non-intrusive blood drawing for diagnostic needs. It is capable of collecting less than 1 mL of blood, these devices speed up the process and minimize the traumatic effects on patients.
This is collectively driven by advancements in point-of-care testing, home healthcare, personalized medicine, increased prevalence of chronic diseases, and remote patient monitoring. Furthermore, innovative approaches to blood testing, self-test machinery, and favorable regulatory mechanisms make the market boom, thereby continuous growth will be effectuated when new patient-headed and minimally invasive healthcare trends develop globally.
Increasingly growing awareness related to healthcare and greater demand for diagnosis through minimal invasion are the reasons that show exponential growth in the market of blood micro-sampling medical devices in the U.S. Due to a high prevalence rate of diabetes and cardiovascular disorders, greater usage of point-of-care testing for diagnostics at a faster rate is expected.
The affordability of the micro-sampling devices ensures home-based self-testing, and telemedicine provides the option for follow-up even from a distance. Companies like BD, Terumo, and Roche are driving technical advancements in lancets and sampling kits toward safety and convenience. The enabling regulatory environment, with FDA approvals, also furthers growth by encouraging innovation as demand for diagnostics increases with the aging population in the U.S.
| Market Size (2024) | USD 2,056.3 Mn |
| Forecast Value (2033) | USD 3,272.6 Mn |
| CAGR (2024-2033) | 5.3% |
| The US Market Size (2024) | USD 686.6 Mn |
| North America Revenue Share (2024) | 39.7% |
| Historical Data | 2018 - 2023 |
| Forecast Data | 2024 - 2033 |
| Base Year | 2023 |
| Estimate Year | 2024 |
| Segments Covered | By Type, By Device Type, By Application |
| Regional Coverage | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
The blood micro-sampling medical devices market presents safety lancets, accounting for a share of 37.1% in 2024, by convenience in handling the device, safety features, and minimum prick discomfort. Automatic mechanisms in the safety lancet cover the needles post-use, avoiding the chances of needle-stick injuries of patients and health professionals; hence, this is very suitable and appropriate for self-testing in-home care.
Because their predetermined depth ensures effective controlled blood sampling, adjustments of the needles by the users are not required; thus, there is high precision and consistency. Such a user-friendly design would be found convenient by people who have little medical knowledge, such as elderly patients or their caregivers, who drive global acceptance and adoption of the safety lancet.
https://dimensionmarketresearch.com/checkout/blood-micro-sampling-medical-devices-market/
North America is projected to dominate with a share of 39.7% in the global blood micro-sampling medical devices market in 2024, given its comprehensive state-of-the-art healthcare infrastructure and increased adoption of decentralized healthcare. High prevalence rates of diabetes, cardiovascular conditions, and other chronic ailments promote demand for frequent, minimally invasive testing-a factor that bodes well for micro-sampling devices.
Strong U.S. reimbursement policies for home healthcare products further underpin adoption. Further, North America leads research and development, with new technologies emerging from key contributors in the market. The concentration of personalized medicine, telemedicine, and self-testing cement its leading position in this fast-changing market.
- ANZ
- ASEAN
- Rest of Asia-Pacific
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
- Saudi Arabia
- UAE
- South Africa
- Israel
- Egypt
- Rest of MEA
- October 2024: Tasso Inc. received FDA clearance for Tasso+, a micro-sampling blood tool simplifying at-home blood collection, aiding chronic condition management with patient-friendly usability.
- September 2024: Abbott launched an advanced FreeStyle Libre glucose monitoring system, incorporating upgraded micro-sampling technology, enhancing accuracy and comfort for diabetes patients.
- August 2024: Siemens Healthineers expanded its point-of-care portfolio, introducing a micro-sampling solution for rapid blood testing, and improving remote patient monitoring, especially in underserved rural regions.
- July 2024: Roche Diagnostics introduced a next-gen lancet-based micro-sampling device offering less invasive blood collection, boosting compliance in chronic disease management.
- June 2024: DarioHealth unveiled a digital-enabled, at-home blood collection device allowing diabetes patients to independently collect and analyze samples without clinical intervention.
- May 2024: Thermo Fisher partnered with a biotech firm to develop micro-sampling devices for genomic testing, accelerating advancements in personalized medicine applications.
The Global is expected to dominate with and is anticipated to grow to
The size is expected to reach a market value of and further anticipated to reach a value of
The Global size is expected to be which is further anticipated to reach at for the forecasted period of
Theis expected to reach a value of and it is further anticipated to reach a market value of
The Global is anticipated to be valued at and is further expected to reach to the constant evolution of medical technology and equipment.
The global size is expected to dominate with and is anticipated to grow to
The Global size is expected to reach a value of and it is further anticipated to reach a market value of
The Global size is expected to reach a value of USD 4.5 billion in 2024, and it is further anticipated to reach a market value of USD 6.6 billion by 2033 at a CAGR of 4.4%.
The Global Western Blotting Market size is expected to reach a value of USD 1,455.4 million in 2024, as it is an important technique that is used in life science experiments and it is further anticipated to reach a market value of USD 2,620.2 million by 2033 at a CAGR of 6.8%.
The Global Wearable Activity Tracker Market size is expected to reach a value of USD 76.1 billion in 2024, and it is further anticipated to reach a market value of USD 258.0 billion by 2033 at a CAGR of 14.5%.
About Dimension Market Research (DMR):
Dimension Market Research (DMR) is a market research and consulting firm based in India & US, with its headquarters located in the USA (New York). The company believes in providing the best and most valuable data to its customers using the best resources analysts work, to create unmatchable insights into the industries, and markets while offering in-depth results of over 30 industries, and all major regions across the world. We also believe that our clients don’t always want what they see, so we provide customized reports as well, as per their specific requirements to create the best possible outcomes for them and enhance their business through our data and insights in every possible way.
